skip to main content

H.R. 5202: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018

About the bill

Source: Republican Policy Committee

H.R. 5202 would allow pharmacists to dispense medication-assisted treatments to doctors, rather than directly to patients, in an attempt to improve dispensing of implantable and injectable therapies developed to make abuse, misuse, and diversion more difficult.

Under the Controlled Substances Act (CSA), pharmacists can only dispense medication-assisted treatments directly to a patient. The legislation would change the CSA to allow pharmacists to dispense these treatments directly to doctors, who can then administer the treatment to the patient in an office-setting, and ensure the patient is also receiving behavioral therapy ...

Sponsor and status

Ryan Costello

Sponsor. Representative for Pennsylvania's 6th congressional district. Republican.

Read Text »
Last Updated: Mar 7, 2018
Length: 5 pages
Introduced:

Mar 7, 2018

Status:

Ordered Reported on May 9, 2018

The committees assigned to this bill sent it to the House or Senate as a whole for consideration on May 9, 2018.

The House Majority Leader indicated on Jun 8, 2018 that this bill may be considered in the week ahead.

Prognosis:

35% chance of being enacted according to Skopos Labs (details)

See Instead:

S. 916 (same title)
Passed Senate (House next) — May 23, 2018

History

Mar 7, 2018
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Apr 25, 2018
 
Considered by Health

A committee held a hearing or business meeting about the bill.

May 9, 2018
 
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Jun 8, 2018
 
On House Schedule

The House indicated that this bill would be considered in the week ahead.

Pending
 
Passed House (Senate next)

Pending
 
Passed Senate

Pending
 
Signed by the President

H.R. 5202 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 5202 — 115th Congress: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018.” www.GovTrack.us. 2018. August 14, 2018 <https://www.govtrack.us/congress/bills/115/hr5202>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.